Renin-Angiotensin System Activation Drives Early Cardiorenal Dysfunction in Normotensive Prediabetes.
6 affiliations
- 1Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
- 2Department of Pharmacology and Therapeutics, Beirut Arab University, Beirut, Lebanon.
- 3Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar.
- 4Research and Innovation Hub, Alamein International University, Alamein, Egypt.
- 5Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
- 6Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas, USA.
Abstract
Introduction
Prediabetes is increasingly recognised as a stage at which cardiovascular and renal dysfunction begin to develop despite the absence of overt metabolic disease. The mechanisms underlying these early alterations remain poorly understood. Because adipose tissues surrounding blood vessels and kidneys can locally generate components of the renin-angiotensin system (RAS), we hypothesised that subclinical RAS activation contributes to early cardiorenal dysfunction in prediabetes.Methods
Using a pre-established normotensive, non-obese rat model of prediabetes induced by 12 weeks of mild hypercaloric feeding, we examined the impact of systemic angiotensin II (AngII) elevation and angiotensin-converting enzyme (ACE) inhibition on cardio-, cerebro- and renovascular function by invasive hemodynamics, ex vivo pressure myography, and ex vivo renal perfusion experiments, respectively.Results
Prediabetic rats exhibited impaired parasympathetic baroreceptor sensitivity and altered renovascular endothelium-dependent vasodilation despite preserved blood pressure and cardiac function. Systemic AngII infusion further exacerbated autonomic and renovascular dysfunction. In contrast, treatment with a non-hypotensive dose of the ACE inhibitor captopril restored baroreceptor sensitivity, improved renovascular endothelial function, reduced brainstem inflammation, and attenuated renal tubular fibrosis. Examination of perivascular and perirenal adipose tissues revealed significantly higher protein concentration of ACE1 in prediabetic rats compared to controls.Conclusion
These findings are consistent with an early activation of RAS contributing to subclinical cardiovascular and renal dysfunction during prediabetes independently of hypertension. Targeting RAS signalling at this early stage may therefore represent a strategy to limit progression of cardiorenal complications along the continuum from prediabetes to diabetes.
Related
- Renal Dysfunction and Cardiorenal Syndrome in Acute Heart Failure: A Systematic Review of Residual Congestion and Decongestion Response
- Cirrhotic Cardiomyopathy and Related Cardiocirculatory Dysfunction: A Systematic Review of Therapeutic Responses and Cardiorenal Outcomes
- LSD1 is upregulated in angiotensin II-induced atrial remodeling and regulates oxidative stress, inflammatory signaling, and NLRP3 inflammasome activation associated with atrial fibrillation susceptibility
- Cardio-renal dysfunction in prediabetes and early type 2 diabetes: insights from myocardial strain and renal Doppler assessment.
- Associations of Angiotensin‐Converting Enzyme 2 Activity With Markers of Endothelial Dysfunction and Oxidative Stress in Young Healthy Adults: The African‐PREDICT Study
BibTeX
@article{bakkar2026reninangiotensin,
title = {{Renin-Angiotensin System Activation Drives Early Cardiorenal Dysfunction in Normotensive Prediabetes.}},
author = {Nour-Mounira Z Bakkar and Rana Ghazi and Nahed Mougharbil and Safaa H Hammoud and Ramzi Sabra and Ali H Eid and Ahmed F El-Yazbi},
journal = {Endocrinology, diabetes \& metabolism},
year = {2026},
month = oct,
doi = {10.1002/edm2.70363},
url = {https://europepmc.org/article/MED/42897734},
note = {CC BY},
}
RIS
TY - JOUR
TI - Renin-Angiotensin System Activation Drives Early Cardiorenal Dysfunction in Normotensive Prediabetes.
AU - Nour-Mounira Z Bakkar
AU - Rana Ghazi
AU - Nahed Mougharbil
AU - Safaa H Hammoud
AU - Ramzi Sabra
AU - Ali H Eid
AU - Ahmed F El-Yazbi
PY - 2026
DA - 2026/10/30
JO - Endocrinology, diabetes & metabolism
DO - 10.1002/edm2.70363
UR - https://europepmc.org/article/MED/42897734
AB - Introduction Prediabetes is increasingly recognised as a stage at which cardiovascular and renal dysfunction begin to develop despite the absence of overt metabolic disease. The mechanisms underlying these early alterations remain poorly understood. Because adipose tissues surrounding blood vessels and kidneys can locally generate components of the renin-angiotensin system (RAS), we hypothesised that subclinical RAS activation contributes to early cardiorenal dysfunction in prediabetes.Methods Using a pre-established normotensive, non-obese rat model of prediabetes induced by 12 weeks of mild hypercaloric feeding, we examined the impact of systemic angiotensin II (AngII) elevation and angiotensin-converting enzyme (ACE) inhibition on cardio-, cerebro- and renovascular function by invasive hemodynamics, ex vivo pressure myography, and ex vivo renal perfusion experiments, respectively.Results Prediabetic rats exhibited impaired parasympathetic baroreceptor sensitivity and altered renovascular endothelium-dependent vasodilation despite preserved blood pressure and cardiac function. Systemic AngII infusion further exacerbated autonomic and renovascular dysfunction. In contrast, treatment with a non-hypotensive dose of the ACE inhibitor captopril restored baroreceptor sensitivity, improved renovascular endothelial function, reduced brainstem inflammation, and attenuated renal tubular fibrosis. Examination of perivascular and perirenal adipose tissues revealed significantly higher protein concentration of ACE1 in prediabetic rats compared to controls.Conclusion These findings are consistent with an early activation of RAS contributing to subclinical cardiovascular and renal dysfunction during prediabetes independently of hypertension. Targeting RAS signalling at this early stage may therefore represent a strategy to limit progression of cardiorenal complications along the continuum from prediabetes to diabetes.
SN - 2398-9238
ER -